Camilla Lindvall Dahlgren is a board member of the Axon Research Foundation and a Professor of Psychology at Oslo New University College.

She holds a PhD in psychology from the University of Oslo and has more than 17 years of experience in eating disorder research, primarily at the Regional Department for Eating Disorders at Oslo University Hospital. She has held research fellowships at the universities of Oxford, Columbia and Berkeley, as well as at Mount Sinai School of Medicine.

In 2024, she established the Eating Disorders Lab at Oslo New University College. Dahlgren’s current research includes psychedelic-assisted therapy for eating disorders and attitudes towards psychedelics in Norway. In 2025, she led the first European study of ketamine-assisted psychotherapy for anorexia nervosa, together with Axon founder Lowan Stewart.